EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

A Multicenter Pilot Randomized Controlled Trial of a Digital Symptom Management Platform (WECARE) for Gastric Cancer Survivors

Geum Jong Song iD, Jae-Seok Min iD, Rock Bum Kim iD, Ki Bum Park, Bang Wool Eom, Jong Hyuk Yun iD, Hoon Hur iD, Jeong Ho Song, Hayemin Lee iD, Su Mi Kim, Eun Young Kim, Hyungkook Yang und 2 weitere

Cancers · 22.04.2026 · 18 (9) · 1329

DOI: 10.3390/cancers18091329 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Cancers, online erschienen am 22.04.2026. Verfasst von Geum Jong Song und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan 31151, Republic of Korea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health & Welfare, Republic of Korea, Korea University, National Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gastric cancer survivors frequently encounter a “care gap” after discharge because of complex postgastrectomy syndromes. We evaluated “WECARE,” a bidirectional digital health platform designed to provide real-time symptom monitoring and multidisciplinary support. The primary goal of this study was to assess the efficacy of the platform by measuring the change in the Korean Quality of Life Questionnaire for Gastric Cancer Survivors (KOQUSS-40) total score over a six-month recovery period.

Methods

This nationwide, multicenter pilot randomized controlled trial was conducted by the Korean Quality of Life in Stomach Cancer Patients Study Group (KOQUSS) across nine tertiary centers in Korea. A total of 88 patients who underwent curative gastrectomy were enrolled. Following an initial optimization phase involving 22 patients, the remaining 66 patients were randomized at a 1:1 ratio to the WECARE group or the control group. The WECARE group used a platform integrating the KOQUSS-40 algorithm for structured symptom reporting, real-time feedback on nutrition and exercise, and educational content on meal planning, symptom coping, and recovery. Assessments were performed at baseline and at 1, 3, and 6 months after discharge.

Results

The WECARE group showed high feasibility and acceptability, with an adherence rate of 86.7% and an 82% satisfaction rate. At 6 months, the KOQUSS-40 total score (primary endpoint) did not differ significantly between the WECARE and control groups (85.3 ± 1.6 vs. 83.8 ± 1.6, p = 0.603). However, the WECARE group showed a numerically favorable recovery trajectory from the acute postoperative phase. Subgroup analysis revealed a positive trend in reflux symptom management in the WECARE group (p = 0.0856). In addition, more than 77% of users reported that the platform improved their self-management capabilities.

Conclusions

The WECARE platform is a feasible and acceptable digital intervention for gastric cancer survivors. Although the primary endpoint was not significantly different, the favorable recovery trajectory, high adherence, and patient engagement support further evaluation in larger studies with longer follow-up and broader healthcare settings.

Schlagwörter

Stichwörter der Autor:innen

Stomach neoplasmspatient-reported outcome measurespostgastrectomy syndromesquality of lifetelemedicine

Autor:innen und Institutionen

  • Department of Surgery, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan 31151, Republic of Korea.
  • Department of Surgery, Korea University College of Medicine, Seoul 02841, Republic of Korea.
  • Division of Foregut Surgery, Korea University Anam Hospital, Seoul 02841, Republic of Korea.
  • Regional Cardiocerebrovascular Disease Center, Gyeongsang National University Hospital, Jinju 52828, Republic of Korea.
  • Department of Surgery, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Daegu 41404, Republic of Korea.
  • Center for Gastric Cancer, National Cancer Center, Goyang 10408, Republic of Korea.

ORCID-Profile: Geum Jong Song, Jae-Seok Min, Rock Bum Kim, Jong Hyuk Yun, Hoon Hur, Hayemin Lee, Sang-Ho Jeong

Förderung

  • Ministry of Health & Welfare, Republic of Korea
  • Korea University
  • National Cancer Center

Zitieren

APA

Song, G. J., Min, J. S., Kim, R. B., Park, K. B., Eom, B. W., Yun, J. H., Hur, H., Song, J. H., Lee, H., Kim, S. M., Kim, E. Y., Yang, H., Lee, J., & Jeong, S. H. (2026). A Multicenter Pilot Randomized Controlled Trial of a Digital Symptom Management Platform (WECARE) for Gastric Cancer Survivors. Cancers, 18(9), 1329. https://doi.org/10.3390/cancers18091329

Vancouver

Song GJ, Min JS, Kim RB, Park KB, Eom BW, Yun JH, et al. A Multicenter Pilot Randomized Controlled Trial of a Digital Symptom Management Platform (WECARE) for Gastric Cancer Survivors. Cancers. 2026;18(9):1329. doi:10.3390/cancers18091329

BibTeX
@article{Song2026,
  author = {Song, Geum Jong and Min, Jae-Seok and Kim, Rock Bum and Park, Ki Bum and Eom, Bang Wool and Yun, Jong Hyuk and Hur, Hoon and Song, Jeong Ho and Lee, Hayemin and Kim, Su Mi and Kim, Eun Young and Yang, Hyungkook and Lee, Joongyub and Jeong, Sang-Ho},
  title = {A Multicenter Pilot Randomized Controlled Trial of a Digital Symptom Management Platform (WECARE) for Gastric Cancer Survivors},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {9},
  pages = {1329},
  doi = {10.3390/cancers18091329}
}
Kostenlos starten →